Valion Bio Inc.
VBIO | NASDAQ
$0.53
-$0.02 (-3.64%)
Nov 2, 2026, 2:31 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2027 Jun 30, 2026 | Q1 2027 Mar 31, 2026 | Q4 2026 Dec 31, 2025 | Q3 2026 Sep 30, 2025 | Q2 2026 Jun 30, 2025 | Q1 2026 Mar 31, 2025 | Q4 2025 Dec 31, 2024 | Q3 2025 Sep 30, 2024 | Q2 2025 Jun 30, 2024 | Q1 2025 Mar 31, 2024 | Q4 2024 Dec 31, 2023 | Q3 2024 Sep 30, 2023 | Q2 2024 Jun 30, 2023 | Q1 2024 Mar 31, 2023 | Q4 2023 Dec 31, 2022 | Q3 2023 Sep 30, 2022 | Q2 2023 Jun 30, 2022 | Q1 2023 Mar 31, 2022 | Q4 2022 Dec 31, 2021 | Q3 2022 Sep 30, 2021 | Q2 2022 Jun 30, 2021 | Q1 2022 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | -302K | 146K | 86K | n/a | 180K | 126K | 140K | 334K | 357K | 282K | 161K | 376K | 408K | 477K | 528K | 428K | 389K | 277K | 268K | 323K |
Cost of Revenue | 358K | n/a | n/a | 291K | 32K | 1K | 419K | 83K | 111K | 168K | 354K | 174K | 104K | 265K | 368K | 417K | 405K | 360K | 393K | 305K | 303K | 303K |
Gross Profit | -358K | n/a | -302K | -145K | 54K | -1K | -239K | 43K | 29K | 166K | 3K | 108K | 57K | 111K | 40K | 60K | 123K | 68K | -4K | -28K | -35K | 20K |
Operating Income | -6.42M | -5.63M | -1.98M | -2.48M | -1.93M | -1.38M | -1.54M | -1.43M | -1.21M | -1.48M | -2.24M | -1.76M | -2.13M | -2.12M | -2.26M | -2.58M | -3.02M | -2.24M | -2.29M | -1.23M | -1.06M | -1.06M |
Interest Income | 11K | 24K | 12K | 4K | 3K | 4K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -7.06M | -6.23M | -1.96M | -2.6M | -1.93M | -1.37M | -1.48M | -1.43M | -1.27M | -1.48M | -2.24M | -1.76M | -2.13M | -2.12M | -2.25M | -2.58M | -3.02M | -2.24M | -3.72M | -2.32M | -1.09M | -1.36M |
Net Income | -7.1M | -6.2M | -2.85M | -2.6M | -1.93M | -1.5M | -1.48M | -1.43M | -1.27M | -1.48M | -2.24M | -1.76M | -2.13M | -2.12M | -2.25M | -2.58M | -3.02M | -2.24M | -3.72M | -2.32M | -1.09M | -1.36M |
Selling & General & Admin | 3.72M | 3.78M | 733K | 1.48M | 1.33M | 1.04M | 971K | 1.05M | 934K | 1.39M | 1.89M | 1.53M | 1.72M | 1.74M | 1.86M | 2.25M | 2.65M | 1.91M | 1.98M | 1.03M | 830K | 881K |
Research & Development | 2.7M | 1.85M | 1.28M | 858K | 655K | 335K | 333K | 421K | 301K | 255K | 358K | 337K | 464K | 488K | 432K | 396K | 495K | 399K | 311K | 173K | 190K | 196K |
Other Expenses | n/a | n/a | -343K | n/a | n/a | -1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 6.42M | 5.63M | 1.67M | 2.34M | 1.99M | 1.38M | 1.3M | 1.47M | 1.24M | 1.65M | 2.25M | 1.87M | 2.18M | 2.23M | 2.3M | 2.64M | 3.14M | 2.31M | 2.29M | 1.2M | 1.02M | 1.08M |
Interest Expense | 691K | 648K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K | n/a | n/a | 155K | 1.17M | 223K | 274K |
Selling & Marketing Expenses | n/a | n/a | -1.02M | 415K | 426K | 179K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 6.42M | 5.63M | 1.67M | 2.63M | 2.02M | 1.38M | 1.72M | 1.56M | 1.35M | 1.82M | 2.6M | 2.04M | 2.29M | 2.49M | 2.66M | 3.06M | 3.55M | 2.67M | 2.68M | 1.51M | 1.32M | 1.38M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 135.2K | 115.35K | n/a | 1.32M | 881.29K | 22.77K | 556.97K | 364.18K | 235.87K | 86.34K | 86.24K | 69.99K | 17.46K | 11.84K | 5.69K | 5.69K | 5.66K | 5.71K | 5.71K | 1.52K | 5.45K | 5.45K |
Shares Outstanding (Diluted) | 135.2K | 115.35K | n/a | 1.32M | 881.29K | 22.77K | 556.97K | 364.18K | 235.87K | 86.34K | 86.24K | 69.99K | 17.46K | 11.84K | 5.69K | 5.69K | 5.66K | 5.71K | 5.71K | 1.52K | 5.45K | 5.45K |
EPS (Basic) | -54.25 | -55.75 | n/a | -1.97 | -2.19 | -65.95 | -2.65 | -3.93 | -5.37 | -17.15 | -26.01 | -25.15 | -121.72 | -178.77 | -395.93 | -453.90 | -533.24 | -391.97 | -651.64 | -1.53K | -200.74 | -248.79 |
EPS (Diluted) | -54.25 | -55.75 | n/a | -1.97 | -2.19 | -65.95 | -2.65 | -3.93 | -5.37 | -17.15 | -26.01 | -25.15 | -121.72 | -178.77 | -395.93 | -453.90 | -533.24 | -391.97 | -651.64 | -1.53K | -200.74 | -248.79 |
EBITDA | -5.76M | -5.4M | -1.92M | -2.48M | -1.93M | -1.37M | -1.27M | -1.43M | -1.17M | -1.44M | -2.2M | -1.72M | -2.08M | -2.07M | -2.21M | -2.54M | -2.98M | -2.24M | -2.27M | -1.23M | -1.05M | -1.06M |
EBIT | -6.37M | -5.58M | -1.92M | -2.48M | -1.93M | -1.37M | -1.54M | -1.43M | -1.21M | -1.48M | -2.24M | -1.76M | -2.13M | -2.12M | -2.26M | -2.58M | -3.02M | -2.24M | -2.29M | -1.23M | -1.06M | -1.06M |
Depreciation & Amortization | 609K | 181K | 3K | n/a | 1K | 1K | 273K | 1K | 32K | 46K | 47K | 44K | 47K | 44K | 45K | 45K | 42K | 2K | 18K | 2K | 2K | 2K |
Add to Watchlist
Select watchlists to add or remove VBIO